Leponex

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2010
0246819732010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Clozapine was one of the major advances in the treatment of schizophrenia since the introduction of the classic antipsychotic… (More)
Is this relevant?
1996
1996
A 67 year-old woman in steady-state treatment with clozapine 150 mg/24 h was co-medicated with 100 mg/24 h of fluvoxamine. During… (More)
Is this relevant?
Review
1995
Review
1995
Ever since clozapine was discovered, researchers have been attempted to answer the question of what makes it different and how to… (More)
Is this relevant?
Review
1992
Review
1992
Leponex (clozapine) is an atypical neuroleptic indicated in severe schizophrenia, launched in France in December 1991. The safety… (More)
Is this relevant?
Review
1989
Review
1989
Granulocytopenia 1 is an established risk of treatment with tricyclic antipsychotic agents, including the phenothiazine group… (More)
  • table 1
  • figure 1
  • table 3
  • table 4
  • figure 2
Is this relevant?
1985
1985
Clozapin holds pharmacologically and clinically a special position among psychoactive drugs. By means of EEG examinations in 25… (More)
Is this relevant?
1978
1978
The authors studied a prolonged (3--5 years) use of leponex in 23 patients with the most progressive forms of schizophrenia… (More)
Is this relevant?
1976
1976
The levels of two endorphines, endogenously occurring morphinomimetic peptides, were measured in serial samples of CSF from seven… (More)
Is this relevant?
1976
1976
The clinical picture and the therapeutic management of a severe case of self-poisoning with Leponex (clozapin) are presented. In… (More)
Is this relevant?
Review
1975
Review
1975
Until now the "neuroleptic threshold" (Haase) was considered to be the efficiency criterion of the antipsychotic effect of a… (More)
Is this relevant?